Sign In

Miyo Yamashita

President & Chief Executive Officer at The Princess Margaret Cancer Foundation

Miyo Yamashita is a market-driven executive with over 20 years of experience, excelling in generating sustainable and profitable growth through leading large transformation and growth initiatives across various functions.

She currently holds the esteemed position of President & CEO at The Princess Margaret Cancer Foundation, the largest cancer charity in Canada, dedicated to fundraising for the renowned Princess Margaret Cancer Centre, a global leader in cancer research.

Prior to her role at The Princess Margaret Cancer Foundation, Miyo Yamashita demonstrated her entrepreneurial skills by establishing and managing her consulting company, which later became part of Deloitte Canada after its acquisition in 2010.

Her professional journey also includes participation on Deloitte Canada's Executive Committee and the global board of directors, showcasing her exceptional leadership abilities and strategic vision.

Miyo Yamashita is multilingual, being fluent in both English and French, and has been recognized for her significant contributions by being named one of Canada's Top 100 Most Powerful Women in 2018.

Her academic qualifications include a Ph.D. in Communications from McGill University, complemented by M.A. and B.A. degrees in Communications and English, respectively, from the University of Manitoba.

Highlights

Jun 10 · linkedin

This past weekend, The Princess Margaret Cancer Foundation hosted the 17th annual Ride to Conquer Cancer, and it was an incredible success! Nearly 5,000 riders from across Canada and around the world came together, raising an astounding $20.6 million for cancer research, education, and care – the highest fundraising total in the event’s history!

The #Ride2Conquer is more than just a cycling event. It's a powerful movement that unites cancer patients, survivors, families, and supporters in the fight against cancer. Thank you to our 2024 Honorary Chair, Som Seif, our top corporate and community fundraising teams, and all our dedicated riders and volunteers. Your commitment is transforming cancer care and giving hope to millions.

Join us in celebrating this achievement and continue supporting groundbreaking research at Princess Margaret Cancer Centre. Together, we can conquer cancer.

#MissionMonday

May 27 · linkedin

Chemotherapy owes its unlikely origin to a World War II naval tragedy. In today's #MissionMonday, I explore this pivotal moment in history and its profound impact on cancer treatment. From the first chemotherapy drug to the innovative therapies at Princess Margaret Cancer Centre, discover how past events have shaped our ongoing fight against cancer.

We also honor the legacy of Dr. David Karnofsky and celebrate the exceptional contributions of Dr. Lillian Siu, recipient of the David A. Karnofsky Memorial Award. Together, we can accelerate progress against cancer and improve outcomes for patients worldwide.

M
Add to my network

Location

Toronto, Ontario, Canada